Effectiveness and cost-effectiveness of diabetes prevention among adherent participants (Q37700457)

22 August 2017

Effectiveness and cost-effectiveness of diabetes prevention among adherent participants (English)

1 reference

cost-effectiveness analysis

22 August 2017

1 reference

Diabetes Prevention Program Research Group

inferred from title

author

11

object named as

Diabetes Prevention Program Research Group

1 reference

22 August 2017

6

Trevor J Orchard

1 reference

22 August 2017

William H Herman

1

1 reference

22 August 2017

Sharon L Edelstein

2

1 reference

22 August 2017

Robert E Ratner

3

1 reference

22 August 2017

Maria G Montez

4

1 reference

22 August 2017

Ronald T Ackermann

5

1 reference

22 August 2017

Mary A Foulkes

7

1 reference

22 August 2017

Ping Zhang

8

1 reference

22 August 2017

Christopher D Saudek

9

1 reference

22 August 2017

Morton B Brown

10

1 reference

22 August 2017

language of work or name

1 reference

1 January 2013

1 reference

American Journal of Managed Care

22 August 2017

1 reference

22 August 2017

19

1 reference

22 August 2017

194-202

1 reference

22 August 2017

3

1 reference

The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS.

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985133

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985133

First versus repeat treatment with a lifestyle intervention program: attendance and weight loss outcomes

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985133

The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985133

Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985133

Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985133

Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985133

The Diabetes Prevention Program (DPP): description of lifestyle intervention

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985133

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985133

Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985133

Behavior therapy for obesity: a comparative investigation of long-term efficacy

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985133

Preventing chronic disease: an important investment, but don't count on cost savings

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985133

Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985133

Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985133

A multivariate logistic regression equation to screen for dysglycaemia: development and validation

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985133

Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985133

Individual versus group therapy for obesity: effects of matching participants to their treatment preferences

1 September 2018

1 reference

12 December 2020

A cost-effectiveness analysis of exercise as a health promotion activity

1 reference

12 December 2020

Cost-effectiveness of the interventions in the primary prevention of diabetes among Asian Indians: within-trial results of the Indian Diabetes Prevention Programme (IDPP)

1 reference

12 December 2020

Cost and clinical implications of diabetes prevention in an Australian setting: a long-term modeling analysis

1 reference

12 December 2020

Identifiers

1 reference

22 August 2017

1 reference